Pharma Mar, S.A. (LON: 0RC6)
London
· Delayed Price · Currency is GBP · Price in EUR 73.87
0.00 (0.00%)
Jul 21, 2022, 6:20 PM BST
Pharma Mar Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 21, 2022 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,168 | 641 | 1,027 | 867 | 1,177 | 669 | Upgrade
|
| Market Cap Growth | 44.84% | -37.61% | 18.42% | -26.28% | 75.82% | 208.86% | Upgrade
|
| Enterprise Value | 1,091 | 527 | 900 | 728 | 1,054 | 719 | Upgrade
|
| Last Close Price | 68.62 | 35.39 | 55.59 | 45.92 | 61.19 | 34.46 | Upgrade
|
| PE Ratio | 2256.71 | 649.51 | 23.46 | 11.12 | 9.57 | - | Upgrade
|
| PS Ratio | 5.22 | 4.67 | 5.90 | 4.49 | 4.86 | 9.20 | Upgrade
|
| PB Ratio | 4.78 | 3.82 | 5.19 | 5.80 | 12.78 | 105.93 | Upgrade
|
| P/TBV Ratio | 4.82 | 3.84 | 5.22 | 5.84 | 12.91 | 75.08 | Upgrade
|
| P/FCF Ratio | - | - | 39.30 | 57.78 | 4.76 | - | Upgrade
|
| P/OCF Ratio | 528.61 | - | 30.22 | 40.22 | 4.71 | - | Upgrade
|
| EV/Sales Ratio | 7.73 | 3.84 | 5.17 | 3.77 | 4.36 | 9.88 | Upgrade
|
| EV/EBITDA Ratio | - | - | 22.60 | 9.12 | 7.39 | - | Upgrade
|
| EV/EBIT Ratio | - | - | 24.11 | 9.37 | 7.51 | - | Upgrade
|
| EV/FCF Ratio | -74.22 | - | 34.41 | 48.46 | 4.26 | - | Upgrade
|
| Debt / Equity Ratio | 0.29 | 0.23 | 0.19 | 0.28 | 0.55 | 11.55 | Upgrade
|
| Debt / EBITDA Ratio | 34.15 | 48.68 | 0.91 | 0.51 | 0.35 | - | Upgrade
|
| Debt / FCF Ratio | - | - | 1.45 | 2.76 | 0.21 | - | Upgrade
|
| Asset Turnover | 0.49 | 0.43 | 0.52 | 0.66 | 1.19 | 0.61 | Upgrade
|
| Inventory Turnover | 0.23 | 0.29 | 0.71 | 1.46 | 1.32 | 0.35 | Upgrade
|
| Quick Ratio | 1.99 | 1.98 | 2.18 | 2.93 | 2.31 | 0.54 | Upgrade
|
| Current Ratio | 2.66 | 2.63 | 2.83 | 3.42 | 2.59 | 0.83 | Upgrade
|
| Return on Equity (ROE) | 0.32% | 0.55% | 24.62% | 66.18% | 249.16% | -73.65% | Upgrade
|
| Return on Assets (ROA) | -0.65% | -0.65% | 6.90% | 16.54% | 43.04% | -7.74% | Upgrade
|
| Return on Capital (ROIC) | -0.91% | -0.95% | 10.67% | 29.89% | 77.41% | -10.68% | Upgrade
|
| Earnings Yield | 0.04% | 0.15% | 4.26% | 8.99% | 10.45% | -1.44% | Upgrade
|
| FCF Yield | -1.26% | -3.98% | 2.54% | 1.73% | 21.01% | -3.57% | Upgrade
|
| Dividend Yield | 1.31% | 1.59% | 1.04% | 1.19% | 0.88% | 1.18% | Upgrade
|
| Payout Ratio | 1836.01% | 1028.06% | 23.83% | 11.71% | 6.42% | - | Upgrade
|
| Buyback Yield / Dilution | 0.81% | 0.12% | 1.31% | 0.77% | -0.29% | Upgrade
| |
| Total Shareholder Return | 1.31% | 2.41% | 1.16% | 2.50% | 1.65% | 0.89% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.